91 related articles for article (PubMed ID: 7955576)
1. Withdrawal of folic acid supplementation in maintenance hemodialysis patients.
Janssen MJ; van den Berg M; van Guldener C; Boers GH; Stehouwer CD
Clin Nephrol; 1994 Aug; 42(2):136-7. PubMed ID: 7955576
[No Abstract] [Full Text] [Related]
2. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C
Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
[TBL] [Abstract][Full Text] [Related]
3. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
[TBL] [Abstract][Full Text] [Related]
4. Effect of different doses of folic acid on serum homocysteine level in patients on hemodialysis.
Tamadon MR; Jamshidi L; Soliemani A; Ghorbani R; Malek F; Malek M
Iran J Kidney Dis; 2011 Mar; 5(2):93-6. PubMed ID: 21368386
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
6. Folic acid treatment of hyperhomocysteinemia in dialysis patients.
Janssen MJ; van Guldener C; de Jong GM; van den Berg M; Stehouwer CD; Donker AJ
Miner Electrolyte Metab; 1996; 22(1-3):110-4. PubMed ID: 8676799
[TBL] [Abstract][Full Text] [Related]
7. Folic acid status of patients with chronic renal failure maintained by dialysis.
Hemmeloff Andersen KE
Clin Nephrol; 1977 Dec; 8(6):510-3. PubMed ID: 598056
[TBL] [Abstract][Full Text] [Related]
8. Relationships between homocysteine and related amino acids in chronic hemodialysis patients.
McDonald SP; Whiting MJ; Tallis GA; Barbara JA
Clin Nephrol; 2001 Jun; 55(6):465-70. PubMed ID: 11434358
[TBL] [Abstract][Full Text] [Related]
9. Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?
van Guldener C
Nephrol Dial Transplant; 2006 May; 21(5):1161-6. PubMed ID: 16490741
[No Abstract] [Full Text] [Related]
10. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
11. The C677T thermolabile variant of methylene tetrahydrofolate reductase on homocysteine, folate and vitamin B12 in a hemodialysis center.
Trimarchi H; Genoud V; Schiel A; Castañon M; Freixas E; Diaz ML; Schropp J; Martino D; Pereyra H; Kordich L
Medicina (B Aires); 2002; 62(2):149-53. PubMed ID: 12038037
[TBL] [Abstract][Full Text] [Related]
12. Is folate and vitamin B12 supplementation necessary in chronic hemodialysis patients with EPO treatment?
Klemm A; Sperschneider H; Lauterbach H; Stein G
Clin Nephrol; 1994 Nov; 42(5):343-5. PubMed ID: 7851040
[No Abstract] [Full Text] [Related]
13. Reduction of plasma homocysteine by folic acid in children with chronic renal failure.
Kang HG; Lee BS; Hahn H; Lee JH; Ha IS; Cheong HI; Choi Y
Pediatr Nephrol; 2002 Jul; 17(7):511-4. PubMed ID: 12172764
[TBL] [Abstract][Full Text] [Related]
14. Elevated homocysteine levels in patients with end-stage renal disease.
Nair AP; Nemirovsky D; Kim M; Geer EB; Farkouh ME; Winston J; Halperin JL; Robbins MJ
Mt Sinai J Med; 2005 Nov; 72(6):365-73. PubMed ID: 16358160
[TBL] [Abstract][Full Text] [Related]
15. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
16. [Homocysteine as a nonlipid factor in the pathogenesis of atherosclerosis].
Magott M
Postepy Hig Med Dosw; 1998; 52(3):259-67. PubMed ID: 9789435
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.
Shojaei MH; Djalali M; Siassi F; Khatami MR; Boroumand MA; Eshragian MR
Iran J Kidney Dis; 2009 Jul; 3(3):141-4. PubMed ID: 19617662
[TBL] [Abstract][Full Text] [Related]
18. Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure.
Chauveau P; Chadefaux B; Coudé M; Aupetit J; Kamoun P; Jungers P
Miner Electrolyte Metab; 1996; 22(1-3):106-9. PubMed ID: 8676798
[TBL] [Abstract][Full Text] [Related]
19. Homocysteinemia and vascular disease in end-stage renal disease.
Dennis VW; Robinson K
Kidney Int Suppl; 1996 Dec; 57():S11-7. PubMed ID: 8941916
[TBL] [Abstract][Full Text] [Related]
20. Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients.
Alvares Delfino VD; de Andrade Vianna AC; Mocelin AJ; Barbosa DS; Mise RA; Matsuo T
Nutrition; 2007 Mar; 23(3):242-7. PubMed ID: 17321110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
